Skip to main content
logo
Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
47.56
+3.13 (7.04%)
Oct 19, 2026, 3:20 PM EDT - Market open

Pulse Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,3929301,071674103439
Market Cap Growth
191.62%-13.12%58.86%553.77%-76.50%-27.42%
Enterprise Value
3,2978431,000633109409
Last Close Price
44.4313.7317.4112.242.7714.81

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2806.862658.43--147.32309.48
PB Ratio
31.6111.549.3215.20-45.8712.30
P/TBV Ratio
34.4712.049.6616.99-14.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2726.822408.93--156.14288.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.090.080.21-33.790.32
Net Debt / Equity Ratio
-0.95-0.91-0.95-0.79-6.59-0.49
Net Debt / EBITDA Ratio
1.150.971.980.83-0.260.28
Net Debt / FCF Ratio
1.551.352.991.06-0.310.32
Asset Turnover
0.010.00--0.010.03
Quick Ratio
9.2710.2311.746.6110.223.37
Current Ratio
9.6310.5311.886.7610.394.30
Return on Equity (ROE)
-78.49%-74.45%-67.31%-200.46%-349.89%-217.33%
Return on Assets (ROA)
-44.34%-42.37%-36.70%-39.75%-54.93%-82.44%
Return on Capital Employed (ROCE)
-80.00%-88.80%-46.00%-83.10%-80.80%-137.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.41%-7.82%-5.00%-6.26%-56.73%-14.51%
FCF Yield
-1.85%-5.85%-3.40%-4.92%-45.98%-12.43%
Buyback Yield / Dilution
-7.37%-15.41%-17.41%-46.56%-21.35%-20.29%
SEC Filings: 10-K · 10-Q